 Jon Kibbie
Concepts (95)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Butyrates | 2 | 2021 | 67 | 0.770 |
Why?
| | Dermatology | 1 | 2024 | 128 | 0.730 |
Why?
| | Alopecia Areata | 1 | 2021 | 13 | 0.700 |
Why?
| | Intestinal Mucosa | 4 | 2021 | 676 | 0.670 |
Why?
| | Histone Deacetylase Inhibitors | 1 | 2021 | 220 | 0.610 |
Why?
| | CD4-Positive T-Lymphocytes | 2 | 2021 | 1129 | 0.530 |
Why?
| | Melanoma | 1 | 2024 | 761 | 0.520 |
Why?
| | Skin Neoplasms | 1 | 2024 | 847 | 0.500 |
Why?
| | Jagged-1 Protein | 1 | 2016 | 22 | 0.500 |
Why?
| | Leprosy | 1 | 2016 | 25 | 0.480 |
Why?
| | Macrophages | 1 | 2016 | 1511 | 0.280 |
Why?
| | Cell Differentiation | 1 | 2016 | 2050 | 0.280 |
Why?
| | Epidermolysis Bullosa Simplex | 1 | 2026 | 14 | 0.240 |
Why?
| | Gastrointestinal Microbiome | 3 | 2019 | 771 | 0.180 |
Why?
| | Alopecia | 1 | 2021 | 37 | 0.180 |
Why?
| | Propionates | 1 | 2021 | 39 | 0.170 |
Why?
| | Acetates | 1 | 2021 | 80 | 0.170 |
Why?
| | Biopsy | 1 | 2024 | 1077 | 0.160 |
Why?
| | Acetylation | 1 | 2021 | 256 | 0.160 |
Why?
| | Pyrroles | 1 | 2021 | 218 | 0.160 |
Why?
| | Bacterial Translocation | 2 | 2019 | 52 | 0.160 |
Why?
| | Interferon-beta | 1 | 2020 | 92 | 0.160 |
Why?
| | Piperidines | 1 | 2021 | 217 | 0.160 |
Why?
| | Interferon-alpha | 1 | 2020 | 197 | 0.150 |
Why?
| | Receptors, Cell Surface | 1 | 2021 | 377 | 0.150 |
Why?
| | Receptors, G-Protein-Coupled | 1 | 2021 | 233 | 0.150 |
Why?
| | Gram-Positive Bacteria | 1 | 2019 | 47 | 0.140 |
Why?
| | Th1 Cells | 1 | 2019 | 139 | 0.140 |
Why?
| | Th17 Cells | 1 | 2019 | 101 | 0.140 |
Why?
| | Gram-Negative Bacteria | 1 | 2019 | 81 | 0.140 |
Why?
| | Gastrointestinal Tract | 1 | 2020 | 208 | 0.130 |
Why?
| | Pyrimidines | 1 | 2021 | 533 | 0.130 |
Why?
| | Endothelial Cells | 2 | 2016 | 870 | 0.130 |
Why?
| | Receptors, Antigen, T-Cell | 1 | 2021 | 668 | 0.130 |
Why?
| | Interleukins | 1 | 2019 | 248 | 0.130 |
Why?
| | Lymphocytes | 1 | 2019 | 382 | 0.130 |
Why?
| | Dendritic Cells | 1 | 2020 | 499 | 0.130 |
Why?
| | Colon | 1 | 2019 | 305 | 0.120 |
Why?
| | Coculture Techniques | 1 | 2016 | 246 | 0.120 |
Why?
| | Histones | 1 | 2021 | 670 | 0.120 |
Why?
| | Interferon-gamma | 1 | 2019 | 784 | 0.110 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2016 | 341 | 0.110 |
Why?
| | Microscopy, Confocal | 1 | 2016 | 321 | 0.110 |
Why?
| | Cells, Cultured | 2 | 2021 | 4155 | 0.110 |
Why?
| | Dysbiosis | 1 | 2017 | 187 | 0.110 |
Why?
| | Retrospective Studies | 2 | 2024 | 17101 | 0.110 |
Why?
| | Antiviral Agents | 1 | 2020 | 768 | 0.110 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2016 | 758 | 0.110 |
Why?
| | HIV-1 | 1 | 2020 | 896 | 0.110 |
Why?
| | Transfection | 1 | 2016 | 940 | 0.100 |
Why?
| | Cell Proliferation | 1 | 2021 | 2499 | 0.100 |
Why?
| | HIV Infections | 2 | 2020 | 3154 | 0.100 |
Why?
| | Lymphocyte Activation | 1 | 2017 | 1126 | 0.100 |
Why?
| | Immunity, Innate | 1 | 2019 | 846 | 0.100 |
Why?
| | Immunohistochemistry | 1 | 2016 | 1718 | 0.090 |
Why?
| | Humans | 10 | 2026 | 144957 | 0.090 |
Why?
| | Phosphines | 1 | 2011 | 18 | 0.080 |
Why?
| | Heterocyclic Compounds | 1 | 2011 | 23 | 0.080 |
Why?
| | Bacteria | 1 | 2017 | 889 | 0.080 |
Why?
| | Male | 5 | 2026 | 72406 | 0.080 |
Why?
| | Transcriptome | 1 | 2016 | 1046 | 0.080 |
Why?
| | Female | 5 | 2026 | 78376 | 0.070 |
Why?
| | Immunologic Factors | 1 | 2011 | 255 | 0.070 |
Why?
| | Signal Transduction | 1 | 2021 | 5233 | 0.070 |
Why?
| | Treatment Outcome | 1 | 2021 | 11695 | 0.060 |
Why?
| | Middle Aged | 3 | 2024 | 35928 | 0.060 |
Why?
| | Adolescent | 2 | 2021 | 22453 | 0.050 |
Why?
| | Gene Expression Regulation | 1 | 2011 | 2609 | 0.040 |
Why?
| | Child | 1 | 2021 | 22657 | 0.040 |
Why?
| | Skin | 1 | 2026 | 758 | 0.040 |
Why?
| | Interleukin-17 | 1 | 2019 | 118 | 0.040 |
Why?
| | Interleukin-1beta | 1 | 2019 | 395 | 0.030 |
Why?
| | DNA, Ribosomal | 1 | 2017 | 94 | 0.030 |
Why?
| | DNA, Bacterial | 1 | 2017 | 342 | 0.030 |
Why?
| | Cluster Analysis | 1 | 2017 | 521 | 0.030 |
Why?
| | Mutation | 1 | 2026 | 4099 | 0.030 |
Why?
| | RNA, Ribosomal, 16S | 1 | 2017 | 559 | 0.030 |
Why?
| | Infant, Newborn | 1 | 2026 | 6434 | 0.030 |
Why?
| | Sequence Analysis, DNA | 1 | 2017 | 824 | 0.030 |
Why?
| | Feces | 1 | 2017 | 513 | 0.020 |
Why?
| | Gene Expression Profiling | 1 | 2020 | 1786 | 0.020 |
Why?
| | Young Adult | 2 | 2020 | 14126 | 0.020 |
Why?
| | Case-Control Studies | 1 | 2020 | 3608 | 0.020 |
Why?
| | Phylogeny | 1 | 2017 | 1019 | 0.020 |
Why?
| | Age Factors | 1 | 2019 | 3335 | 0.020 |
Why?
| | Adult | 3 | 2020 | 40506 | 0.020 |
Why?
| | Phenotype | 1 | 2019 | 3164 | 0.020 |
Why?
| | Catalysis | 1 | 2011 | 322 | 0.020 |
Why?
| | Structure-Activity Relationship | 1 | 2011 | 570 | 0.020 |
Why?
| | Molecular Structure | 1 | 2011 | 501 | 0.020 |
Why?
| | Microbiota | 1 | 2017 | 781 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2019 | 8279 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2017 | 5872 | 0.010 |
Why?
| | Inflammation | 1 | 2011 | 2880 | 0.010 |
Why?
| | Aged | 1 | 2019 | 25947 | 0.010 |
Why?
|
|
Kibbie's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|